SA
Sign upLog In

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Revenue

$2.59B

TTM · Period ending: · USD

BIO logo

BIO Revenue

Latest reported$2.59B
BIO TTM Revenue ($126.50M → $2.59B)
High-resolution chart · PNG

BIO revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
2,592,700,000
2,589,300,000
2,589,900,000
2,583,200,000
2,557,475,000
2,554,204,000
2,541,080,000
2,566,500,000
2,580,209,000
2,562,604,000
2,605,238,000
2,671,262,000
2,720,366,000
2,769,042,000
2,779,031,000
2,802,249,000
2,804,730,000
2,870,979,000
2,895,811,000
2,922,545,000
2,979,615,000
2,879,829,000
2,700,778,000
2,545,626,000
2,380,215,000
2,293,585,000
2,329,324,000
2,311,659,000
2,304,772,000
2,289,277,000
2,292,569,000
2,290,109,000
2,293,001,000
2,282,866,000
2,211,621,000
2,160,153,000
2,111,173,000
2,084,915,000
2,097,026,000
2,068,172,000
2,067,276,000
2,028,492,000
2,017,817,000
2,019,441,000
2,047,108,000
2,107,791,000
2,138,521,000
2,175,044,000
2,179,455,000
2,153,877,000
2,142,366,000
2,132,694,000
2,103,898,000
2,097,529,000
2,082,630,000
2,069,235,000
2,045,634,000
2,063,451,000
2,074,685,000
2,073,529,000
2,057,011,000
2,011,999,000
1,958,005,000
1,927,118,000
1,888,471,000
1,878,024,000
1,837,545,000
1,784,244,000
1,737,136,000
1,717,923,000
1,743,101,000
1,764,365,000
1,776,088,000
1,673,988,000
1,560,741,000
1,461,052,000
1,344,445,000
1,309,467,000
1,288,100,000
1,273,930,000
1,238,136,000
1,216,597,000
1,190,152,000
1,180,985,000
1,181,566,000
1,157,190,000
1,126,434,000
1,093,908,000
1,052,242,000
1,041,097,000
1,024,058,000
1,003,382,000
980,180,000
957,354,000
928,507,000
892,720,000
883,103,000
844,329,000
825,023,000
817,509,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.